Focus Group – Help make our new clinical trial for lung cancer more patient friendly
We are looking for people who have been affected by Stage 3 or 4 non-small cell lung cancer (NSCLC) to take part in a focus group to help us develop a clinical trial protocol. A clinical trial protocol sets out which patients can take part in a clinical trial and which tests will be performed and when.
About this opportunity:
The Centre for Drug Development (CDD) conducts early phase (Phase I and II) clinical trials of new drugs that they hope will become cancer treatments in the future. They are looking for people who have been affected by Stage 3 or 4 non-small cell lung cancer (NSCLC) to take part in a focus group to help develop a new patient-friendly clinical trial protocol.
A clinical trial protocol explains in detail which patients can take part in a clinical trial and which tests will be performed and when.
The CDD recently asked people affected by lung cancer and who have experience of being on a clinical trial to complete a survey that asked questions about the acceptability of procedures that are required on a clinical trial. These insights were used to help shape the early trial design. The next stage is to write the clinical trial protocol.
If you would like to be involved, you will be required to review the document between 17 December 2019 and 10 January 2020. This will be followed by a 2-3 hour face-to-face meeting during the week commencing 13 January 2020 in London to discuss your thoughts with other people affected by cancer and the CRUK CDD trial team.
Closing date: Closed
Event Date: 2-3 hour meeting, week commencing 13 January 2020
Location: CRUK Head Office, 2 Redman Place, Stratford, E20 1JQ
Payment and Expenses: Your travel costs will be reimbursed, and we will pay you £80 honorarium for your time reviewing the protocol and during the meeting. Refreshments at the face-to-face meeting will be provided.
Time commitment: Reviewing the document should take up to 3 hours, followed by a one-off 2-3 hour face-to-face meeting in London.
Support: If you are interested and/or would like more information about this opportunity, please contact Helen Wilkinson (email@example.com).
At CRUK we value diversity and we're committed to creating an inclusive environment that facilitates the involvement of all people affected by cancer. We actively encourage applications from people of all backgrounds and cultures and believe that a diverse involvement network (or range of views and insight) will help us to better represent people affected by cancer and make a difference for cancer patients.
Get in touch
To become a member of Your Involvement Network and help us beat cancer, please click below and complete your details.